ImmunoGen Inc (NASDAQ:IMGN)

12.15
Delayed Data
As of Jun 22
 +0.47 / +4.02%
Today’s Change
4.80
Today|||52-Week Range
13.41
+89.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues59.9M85.5M43.0M115.4M
 
 
 
 
 
Depreciation And Amortization4.6M5.5M6.1M6.0M
 
 
 
 
 
 
Operating ExpensesGross Income----36.9M--
 
 
General Expenses126.8M134.5M163.0M167.7M
 
 
 
 
 
Research And Development107.0M111.8M133.1M139.7M
 
 
 
 
 
Total Operating Expenses131.4M140.0M169.1M173.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-71.5M-54.5M-126.1M-58.2M
 
 
 
 
 
Extraordinary Credit2.0K0.000.000.00
 
 
Extraordinary Charge0.000.00-4.4M-23.7M
 
 
 
Interest Expense On Debt--5.4M21.8M16.7M
 
 
 
 
Other Expenses121.0K-916.0K-5.9M1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-71.4M-60.7M-157.8M-96.0M
 
 
 
 
 
Net Income-71.4M-60.7M-157.8M-96.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS85.5M86.0M87.1M98.1M
 
 
 
 
 
Shares To Calculate EPS Diluted85.5M86.0M87.1M98.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.83-$0.71-$0.91-$0.98
 
 
 
 
 
EPS Diluted-$0.83-$0.71-$1.81-$0.98